Form 4 Filing for Journey Medical Corp - Insider Transaction

This filing details a Form 4 submission by Lindsay A. Rosenwald, MD, a director at Journey Medical Corp. On June 25, 2026, 10,000 restricted stock units were granted to Dr. Rosenwald under the Issuer's 2015 Stock Plan, as amended. These units are scheduled to vest on June 25, 2027. The transaction is coded as an acquisition (Code A) with a transaction price of $0.00 per share. Following this grant, the post-transaction number of shares owned is 221,146. The filing also notes that 176,470 shares are held indirectly, with the nature of ownership detailed in Footnote 3, indicating shares are held by a limited liability company where Dr. Rosenwald, as managing member, is deemed to have voting and investment power. Footnote 2 clarifies that the reported shares include restricted stock units vesting over various periods.